Ways to improve breast cancer patients' management and clinical outcome: The 2020 Assisi Think Tank Meeting.

BCRA-mutated patients Breast cancer Contralateral breast cancer prevention De-escalating therapy Oligometastatic disease Radiation therapy Stereotactic radiation therapy

Journal

Critical reviews in oncology/hematology
ISSN: 1879-0461
Titre abrégé: Crit Rev Oncol Hematol
Pays: Netherlands
ID NLM: 8916049

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 08 06 2021
revised: 19 07 2022
accepted: 29 07 2022
pubmed: 3 8 2022
medline: 24 8 2022
entrez: 2 8 2022
Statut: ppublish

Résumé

We report on the third Assisi Think Tank Meeting (ATTM) on breast cancer, a brainstorming project which involved European radiation and clinical oncologists who were dedicated to breast cancer research and treatment. Held on February 2020, the ATTM aimed at identifying key clinical questions in current clinical practice and "grey" areas requiring research to improve management and outcomes. Before the meeting, three key topics were selected: 1) managing patients with frailty due to either age and/or multi-morbidity; 2) stereotactic radiation therapy and systemic therapy in the management of oligometastatic disease; 3) contralateral breast tumour prevention in BCRA-mutated patients. Clinical practice in these areas was investigated by means of an online questionnaire. In the lapse period between the survey and the meeting, the working groups reviewed data, on-going studies and the clinical challenges which were then discussed in-depth and subjected to intense brainstorming during the meeting; research protocols were also proposed. Methodology, outcome of discussions, conclusions and study proposals are summarized in the present paper. In conclusion, this report presents an in-depth analysis of the state of the art, grey areas and controversies in breast cancer radiation therapy and discusses how to confront them in the absence of evidence-based data to guide clinical decision-making.

Identifiants

pubmed: 35917884
pii: S1040-8428(22)00198-6
doi: 10.1016/j.critrevonc.2022.103774
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

103774

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Cynthia Aristei (C)

Radiation Oncology Section, Department of Medicine and Surgery, University of Perugia and Perugia General Hospital, Perugia, Italy. Electronic address: cynthia.aristei@unipg.it.

Yasemin Bölükbaşı (Y)

Koc University, Faculty of Medicine, Department of Radiation Oncology, Istanbul, Turkey.

Orit Kaidar-Person (O)

Breast Radiation Unit, Radiation Oncology, Sheba Medical Center, Ramat Gan, Israel.

Raphael Pfeffer (R)

Oncology Institute, Assuta Medical Center, Tel Aviv and Ben Gurion University Medical School, Israel.

Meritxell Arenas (M)

Universitat Rovira I Virgili, Radiation Oncology Department, Hospital Universitari Sant Hoan de Reus, IISPV, Spain.

Liesbeth J Boersma (LJ)

Radiation Oncology (Maastro), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.

Antonella Ciabattoni (A)

Department of Radiation Oncology, San Filippo Neri Hospital, ASL Rome 1, Rome, Italy.

Charlotte E Coles (CE)

Department of Oncology, University of Cambridge, UK.

Pierfrancesco Franco (P)

Depatment of Translational Medicine, University of Eastern Piedmont and Department of Radiation Oncology, 'Maggiore della Carità' University Hospital, Novara, Italy.

Marco Krengli (M)

Depatment of Translational Medicine, University of Eastern Piedmont and Department of Radiation Oncology, 'Maggiore della Carità' University Hospital, Novara, Italy.

Maria Cristina Leonardi (MC)

Division of Radiation Oncology, IEO European Institute of Oncology, IRCCS, Milan, Italy.

Fabio Marazzi (F)

Unità Operativa di Radioterapia Oncologica, Dipartimento di Diagnostica per Immagine, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Gemelli IRCSS Roma, Italy.

Valeria Masiello (V)

Unità Operativa di Radioterapia Oncologica, Dipartimento di Diagnostica per Immagine, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Gemelli IRCSS Roma, Italy.

Icro Meattini (I)

Department of Experimental and Clinical Biomedical Sciences "M. Serio", University of Florence & Radiation Oncology Unit - Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.

Angel Montero (A)

Department of Radiation Oncology, University Hospital HM Sanchinarro, HM Hospitales, Madrid, Spain.

Birgitte Offersen (B)

Department of Experimental Clinical Oncology, Department of Oncology, Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.

Maria Lurdes Trigo (ML)

Service of Brachytherapy, Department of Image and Radioncology, Instituto Português Oncologia Porto Francisco Gentil E.P.E., Portugal.

Céline Bourgier (C)

Radiation Oncology, ICM-Val d'Aurelle, Univ Montpellier, Montpellier, France.

Domenico Genovesi (D)

Radiation Oncology, Ospedale Clinicizzato Chieti and University "G. d'Annunzio", Chieti, Italy.

Vassilis Kouloulias (V)

2nd Department of Radiology, Radiotherapy Unit, Medical School, National and Kapodistrian University of Athens, Greece.

Alessio G Morganti (AG)

DIMES, Alma Mater Studiorum Bologna University, Bologna, Italy; Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Alma Mater Studiorum Bologna University; Bologna, Italy.

Bruno Meduri (B)

Radiation Oncology Unit, University Hospital of Modena, Modena, Italy.

Nadia Pasinetti (N)

Radiation Oncology Service, ASST Valcamonica Esine and Brescia University, Brescia, Italy.

Sara Pedretti (S)

Istituto del Radio "O.Alberti" - Spedali Civili Hospital and Brescia University, Brescia.

Elisabetta Perrucci (E)

Radiation Oncology Section, Perugia General Hospital, Perugia, Italy.

Sofia Rivera (S)

Radiation Oncology, Institut Gustave Roussy, Villejuif, France.

Vincenzo Tombolini (V)

Radiation Oncology, Department of Radiological, Oncological and Pathological Science, University "La Sapienza", Roma, Italy.

Cristiana Vidali (C)

Former Senior Assistant Department of Radiation Oncology, Azienda Sanitaria Universitaria Integrata di Trieste, Trieste, Italy.

Vincenzo Valentini (V)

Division of Radiation Oncology, IEO European Institute of Oncology, IRCCS, Milan, Italy.

Philip Poortmans (P)

Department of Radiation Oncology, Iridium Kankernetwerk, Antwerp, Belgium; University of Antwerp, Faculty of Medicine and Health Sciences, Antwerp, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH